Here are five key notes on the company’s financial report:
1. Revenue was up 30 percent to $18.4 million in the third quarter. Pathology revenue was up 23 percent.
2. International revenue grew 188 percent year-over-year and is now 12 percent of total revenue.
3. Gross profit hits $6.1 million, 33.4 percent over the same period last year.
4. Net loss for the quarter was $11.6 million, or $0.47 per share.
5. Total revenue is expected to reach $72 million to $74 million for the full year. Net loss is projected at$60 million to $61 million.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
